Walleye Capital’s Twist Bioscience TWST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.04M Buy
+5,400
New +$667K ﹤0.01% 3437
2026
Q1
– Sell
-1,500
Closed -$47.6K – 5003
2025
Q4
$47.6K Buy
+1,500
New +$46.8K ﹤0.01% 4089
2025
Q1
– Sell
-1,000
Closed -$46.5K – 5156
2024
Q4
$46.5K Buy
+1,000
New +$45.2K ﹤0.01% 4375
2024
Q3
– Sell
-1,300
Closed -$64.1K – 5893
2024
Q2
$64.1K Buy
+1,300
New +$53K ﹤0.01% 4865
2024
Q1
– Sell
-1,600
Closed -$59K – 5907
2023
Q4
$59K Sell
1,600
-7,700
-83% -$178K ﹤0.01% 4252
2023
Q3
$188K Sell
9,300
-9,300
-50% -$204K ﹤0.01% 3594
2023
Q2
$381K Buy
18,600
+18,100
+3,620% +$271K ﹤0.01% 2636
2023
Q1
$7.54K Buy
+500
New +$11K ﹤0.01% 3583

Other funds holding TWST

Walleye Capital's TWST Position: Q3 2026 in Review

Walleye Capital opened a new position in Twist Bioscience (TWST) in Q3 2026: 600 shares worth $116K. The stake represents ﹤0.01% of the portfolio and ranks #5120 among its holdings. This is a return to the name: Walleye Capital previously reported a position in TWST as recently as Q2 2024.

Walleye Capital first reported a position in TWST in Q4 2020 and has held it in 6 quarters since. The position peaked at $1.24M in Q1 2023. 435 funds tracked by Wall St. Rank hold TWST as of Q3 2026.

  • Walleye Capital held 600 shares of Twist Bioscience worth $116K as of Q3 2026.
  • Twist Bioscience was a new Walleye Capital position in Q3 2026.
  • Twist Bioscience made up ﹤0.01% of Walleye Capital's portfolio in Q3 2026, its #5120 holding.
  • Walleye Capital first reported a position in Twist Bioscience in Q4 2020 and has held it in 6 quarters since.
  • Walleye Capital's Twist Bioscience position peaked at $1.24M in Q1 2023.
  • 435 funds tracked by Wall St. Rank held Twist Bioscience as of Q3 2026.

Based on Walleye Capital's 13F filing for Q3 2026, filed 13 Nov 2026.